Curtin University Homepage
  • Library
  • Help
    • Admin

    espace - Curtin’s institutional repository

    JavaScript is disabled for your browser. Some features of this site may not work without it.
    View Item 
    • espace Home
    • espace
    • Curtin Research Publications
    • View Item
    • espace Home
    • espace
    • Curtin Research Publications
    • View Item

    Anti-Tumour Effect of a Chitosan Delivery System for Doxorubicin

    Access Status
    Fulltext not available
    Authors
    Tan, M.
    Choong, P.
    Dass, Crispin
    Date
    2010
    Type
    Journal Article
    
    Metadata
    Show full item record
    Citation
    Tan, M. and Choong, P. and Dass, C. 2010. Anti-Tumour Effect of a Chitosan Delivery System for Doxorubicin. Advanced Materials Research. 93-94: pp. 703-706.
    Source Title
    Advanced Materials Research
    DOI
    10.4028/www.scientific.net/AMR.93-94.703
    ISSN
    1022-6680
    URI
    http://hdl.handle.net/20.500.11937/26348
    Collection
    • Curtin Research Publications
    Abstract

    Used against a variety of tumours, doxorubicin (DOX), causes multiple side-effects in patients, especially in high doses required to control tumour growth. A drug delivery system (DDS) was developed to deliver DOX. Through DOX encapsulation into chitosan DDS, novel DOX microparticles (DMPs) were formed. Multiple optimisation steps produced DMPs which caused tumour cell death. Treatment of mice bearing tumours with DMP decreased tumour growth and spread, with no visible side-effects. There are plans to evaluate this delivery vehicle more closely towards clinical development and testing.

    Related items

    Showing items related by title, author, creator and subject.

    • Immune-mediated ECM depletion improves tumour perfusion and payload delivery
      Yeow, Y.L.; Kotamraju, V.R.; Wang, X.; Chopra, M.; Azme, N.; Wu, J.; Schoep, T.D.; Delaney, D.S.; Feindel, K.; Li, J.; Kennedy, K.M.; Allen, W.M.; Kennedy, B.F.; Larma, I.; Sampson, D.D.; Mahakian, L.M.; Fite, B.Z.; Zhang, H.; Friman, T.; Mann, A.P.; Aziz, F.A.; Kumarasinghe, M.P.; Johansson, M.; Ee, H.C.; Yeoh, G.; Mou, L.; Ferrara, K.W.; Billiran, H.; Ganss, R.; Ruoslahti, E.; Hamzah, Juliana (2019)
      High extracellular matrix (ECM) content in solid cancers impairs tumour perfusion and thus access of imaging and therapeutic agents. We have devised a new approach to degrade tumour ECM, which improves uptake of circulating ...
    • Microsphere distribution and radiation dosimetry in human liver following Yttrium-90 microsphere therapy.
      Campbell, Andrew M. (2000)
      The microscopic distribution of microspheres and the resulting radiation dose deposition patterns in human liver following hepatic arterial infusion of 90Y labelled microspheres have been investigated. Tissue samples from ...
    • Novel strategies for inhibiting cancer growth
      Schaefer, Rainer (2008)
      At present, most cancers are treated with surgery, radiotherapy and chemotherapy, used alone or in combination. Surgery and radiotherapy are the primary treatment modalities after early detection of cancers and they ...
    Advanced search

    Browse

    Communities & CollectionsIssue DateAuthorTitleSubjectDocument TypeThis CollectionIssue DateAuthorTitleSubjectDocument Type

    My Account

    Admin

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    Follow Curtin

    • 
    • 
    • 
    • 
    • 

    CRICOS Provider Code: 00301JABN: 99 143 842 569TEQSA: PRV12158

    Copyright | Disclaimer | Privacy statement | Accessibility

    Curtin would like to pay respect to the Aboriginal and Torres Strait Islander members of our community by acknowledging the traditional owners of the land on which the Perth campus is located, the Whadjuk people of the Nyungar Nation; and on our Kalgoorlie campus, the Wongutha people of the North-Eastern Goldfields.